Dina Faddah

Dina Faddah is a prominent scientist specializing in Discovery Biology and Gene Therapy at Neurocrine Biosciences in San Diego, California. She held this position from February 2021 until August 2023, contributing significantly to the field of pharmacology and drug discovery. Currently, she serves as a Senior Scientist in Developmental Sciences at Altos Labs since August 2023.1

Educational Background

• Ph.D. in Biology from the Massachusetts Institute of Technology (MIT), where she focused on induced pluripotent stem cells (iPSCs) and gene regulation from 2009 to 2014.
• B.S. in Biology and Chemistry with Honors from the University of North Carolina at Chapel Hill (2002-2006).1

Professional Experience

• Postdoctoral Fellowships:
  • Salk Institute for Biological Studies (2016-2019), investigating obesity and Parkinson's disease using patient-specific iPSCs.
  • UCSF (2014-2016), focusing on neural circuits related to feeding behavior in mice.
• Vertex Pharmaceuticals: Served as a Vertex Fellow in Pharmacology, developing assays for pain drug discovery from July 2019 to October 2020.1

Research Contributions

Dina has published multiple papers, including two as the first author, and has presented her research at international conferences. Her work has primarily revolved around understanding complex biological processes and developing innovative therapies.1

Honors and Awards

She has received several accolades throughout her career, including:

• National Science Foundation Graduate Research Fellowship.
• MIT Graduate Woman of Excellence award.
• HHMI Postdoctoral Fellow of the Jane Coffin Childs Memorial Fund for Medical Research.1

Dina Faddah's expertise and contributions to neuroscience and pharmacology underscore her significant role in advancing medical science through innovative research and development.